These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 19427172

  • 1. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study).
    Baeza I, Graell M, Moreno D, Castro-Fornieles J, Parellada M, González-Pinto A, Payá B, Soutullo C, de la Serna E, Arango C.
    Schizophr Res; 2009 Sep; 113(2-3):129-37. PubMed ID: 19427172
    [Abstract] [Full Text] [Related]

  • 2. Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis.
    González-Ortega I, Alberich S, Echeburúa E, Aizpuru F, Millán E, Vieta E, Matute C, González-Pinto A.
    PLoS One; 2015 Sep; 10(4):e0123707. PubMed ID: 25875862
    [Abstract] [Full Text] [Related]

  • 3. Cognitive functioning in children and adolescents in their first episode of psychosis: differences between previous cannabis users and nonusers.
    de la Serna E, Mayoral M, Baeza I, Arango C, Andrés P, Bombin I, González C, Rapado M, Robles O, Rodríguez-Sánchez JM, Zabala A, Castro-Fornieles J.
    J Nerv Ment Dis; 2010 Feb; 198(2):159-62. PubMed ID: 20145493
    [Abstract] [Full Text] [Related]

  • 4. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
    Tosato S, Lasalvia A, Bonetto C, Mazzoncini R, Cristofalo D, De Santi K, Bertani M, Bissoli S, Lazzarotto L, Marrella G, Lamonaca D, Riolo R, Gardellin F, Urbani A, Tansella M, Ruggeri M, PICOS-VENETO Group.
    J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
    [Abstract] [Full Text] [Related]

  • 5. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
    Ruiz-Veguilla M, Gurpegui M, Barrigón ML, Ferrín M, Marín E, Rubio JL, Gutiérrez B, Pintor A, Cervilla J.
    Schizophr Res; 2009 Feb; 107(2-3):158-64. PubMed ID: 18805673
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic and symptomatological features in chronic psychotic patients according to cannabis use status.
    Maremmani I, Lazzeri A, Pacini M, Lovrecic M, Placidi GF, Perugi G.
    J Psychoactive Drugs; 2004 Jun; 36(2):235-41. PubMed ID: 15369205
    [Abstract] [Full Text] [Related]

  • 7. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
    van der Meer FJ, Velthorst E, Genetic Risk and Outcome of Psychosis (GROUP) Investigators.
    Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244
    [Abstract] [Full Text] [Related]

  • 8. The Effect of Changes in Cannabis Exposure on Psychotic Symptoms in Patients With Comorbid Cannabis Use Disorder.
    Toftdahl NG, Nordentoft M, Hjorthøj C.
    J Dual Diagn; 2016 Jul; 12(2):129-36. PubMed ID: 27070732
    [Abstract] [Full Text] [Related]

  • 9. Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate.
    Pelizza L, Azzali S, Garlassi S, Paterlini F, Scazza I, Chiri LR, Pupo S, Raballo A.
    Eur Child Adolesc Psychiatry; 2018 Jun; 27(6):725-737. PubMed ID: 29058115
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of sex on substance use between first episode psychosis patients and healthy people.
    Núñez C, Ochoa S, Huerta-Ramos E, Baños I, Barajas A, Dolz M, Sánchez B, Del Cacho N, GENIPE Group, Usall J.
    Compr Psychiatry; 2016 Aug; 69():169-78. PubMed ID: 27423358
    [Abstract] [Full Text] [Related]

  • 11. The child and adolescent first-episode psychosis study (CAFEPS): design and baseline results.
    Castro-Fornieles J, Parellada M, Gonzalez-Pinto A, Moreno D, Graell M, Baeza I, Otero S, Soutullo CA, Crespo-Facorro B, Ruiz-Sancho A, Desco M, Rojas-Corrales O, Patiño A, Carrasco-Marin E, Arango C, CAFEPS group.
    Schizophr Res; 2007 Mar; 91(1-3):226-37. PubMed ID: 17267179
    [Abstract] [Full Text] [Related]

  • 12. Cannabis--psychosis pathway independent of other types of psychopathology.
    Ferdinand RF, van der Ende J, Bongers I, Selten JP, Huizink A, Verhulst FC.
    Schizophr Res; 2005 Nov 15; 79(2-3):289-95. PubMed ID: 16125368
    [Abstract] [Full Text] [Related]

  • 13. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.
    Stone JM, Fisher HL, Major B, Chisholm B, Woolley J, Lawrence J, Rahaman N, Joyce J, Hinton M, Johnson S, Young AH, MiData Consortium.
    Psychol Med; 2014 Feb 15; 44(3):499-506. PubMed ID: 23701858
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis.
    Schimmelmann BG, Conus P, Cotton S, Kupferschmid S, McGorry PD, Lambert M.
    Eur Psychiatry; 2012 Aug 15; 27(6):463-9. PubMed ID: 21616646
    [Abstract] [Full Text] [Related]

  • 15. Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis.
    Faridi K, Joober R, Malla A.
    Schizophr Res; 2012 Oct 15; 141(1):78-82. PubMed ID: 22910403
    [Abstract] [Full Text] [Related]

  • 16. Cannabis use predicts shorter duration of untreated psychosis and lower levels of negative symptoms in first-episode psychosis: a South African study.
    Burns JK, Jhazbhay K, Emsley R.
    Afr J Psychiatry (Johannesbg); 2010 Nov 15; 13(5):395-9. PubMed ID: 21390411
    [Abstract] [Full Text] [Related]

  • 17. Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.
    Machielsen M, van der Sluis S, de Haan L.
    Aust N Z J Psychiatry; 2010 Aug 15; 44(8):721-8. PubMed ID: 20636193
    [Abstract] [Full Text] [Related]

  • 18. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH.
    Aust N Z J Psychiatry; 2010 Mar 15; 44(3):230-6. PubMed ID: 20180725
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis.
    Barrigón ML, Gurpegui M, Ruiz-Veguilla M, Diaz FJ, Anguita M, Sarramea F, Cervilla J.
    J Psychiatr Res; 2010 May 15; 44(7):413-20. PubMed ID: 19900684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.